The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

M.L. Rothenberg

University of Texas Health Science Center at San Antonio

USA

[email]@*.vanderbilt.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of Texas Health Science Center at San Antonio, USA. 1998 - 2001
  • Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5536, USA. 2001
  • Vanderbilt-Ingram Cancer Center, Nashville, TN 37232-6307, USA. 2001
  • Vanderbilt University Medical Center, Tennessee, USA. 2000
  • Vanderbilt University Medical Center, Division of Medical Oncology, Department of Medicine, Nashville, USA. 1998

References

  1. Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond. Rothenberg, M.L. Oncologist (2001) [Pubmed]
  2. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. Rothenberg, M.L., Meropol, N.J., Poplin, E.A., Van Cutsem, E., Wadler, S. J. Clin. Oncol. (2001) [Pubmed]
  3. Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. Rothenberg, M.L., Kuhn, J.G., Schaaf, L.J., Rodriguez, G.I., Eckhardt, S.G., Villalona-Calero, M.A., Rinaldi, D.A., Hammond, L.A., Hodges, S., Sharma, A., Elfring, G.L., Petit, R.G., Locker, P.K., Miller, L.L., von Hoff, D.D. Ann. Oncol. (2001) [Pubmed]
  4. Efficacy of oxaliplatin in the treatment of colorectal cancer. Rothenberg, M.L. Oncology (Williston Park, N.Y.) (2000) [Pubmed]
  5. New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors. Rothenberg, M.L., Nelson, A.R., Hande, K.R. Oncologist (1998) [Pubmed]
  6. Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. Rothenberg, M.L., Sharma, A., Weiss, G.R., Villalona-Calero, M.A., Eckardt, J.R., Aylesworth, C., Kraynak, M.A., Rinaldi, D.A., Rodriguez, G.I., Burris, H.A., Eckhardt, S.G., Stephens, C.D., Forral, K., Nicol, S.J., Von Hoff, D.D. Ann. Oncol. (1998) [Pubmed]
 
WikiGenes - Universities